Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | LEGN | CYTK | ||
| Company | Reata Pharma | Legend Biotech Corp ADR | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 172.34 | 38.59 | 50.24 | ||
| High | 172.46 | 39.69 | 52.01 | ||
| Low | 172.32 | 37.40 | 49.64 | ||
| Last | 172.36 | 37.42 | 51.94 | ||
| Change | +0.04 | -0.77 | +1.72 | ||
| % Change | +0.02% | -2.02% | +3.42% | ||
| Volume | 1,988,500 | 1,617,300 | 1,288,800 | ||
| 20-Day Average Volume | 810,510 | 1,571,605 | 1,195,210 | ||
| Previous Close | 172.32 | 38.19 | 50.22 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 42.39 | 53.53 | ||
| 20-Day Raw Stochastic | 97.36% | 0.19% | 23.59% | ||
| 20-Day Relative Strength | 81.56% | 31.63% | 45.29% | ||
| Weighted Alpha | +177.60 | -42.63 | -9.29 | ||
| Today's Opinion | 100% Buy | 100% Sell | 96% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 96% Sell | ||
| Last Month's Opinion | 100% Buy | 72% Sell | 48% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | -6.54% since 11/11/24 | -11.40% since 11/11/24 | ||
| Low | 171.96 on 09/19/23 | 37.40 on 11/18/24 | 49.64 on 11/18/24 | ||
| High | 172.46 on 09/25/23 | 41.87 on 11/12/24 | 58.95 on 11/12/24 | ||
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | -12.71% since 10/18/24 | -5.51% since 10/18/24 | ||
| Low | 168.67 on 09/05/23 | 37.40 on 11/18/24 | 49.64 on 11/18/24 | ||
| High | 172.46 on 09/25/23 | 47.79 on 11/05/24 | 59.39 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | -34.22% since 08/16/24 | -8.07% since 08/16/24 | ||
| Low | 88.80 on 06/27/23 | 37.40 on 11/18/24 | 49.64 on 11/18/24 | ||
| High | 172.46 on 09/25/23 | 59.62 on 09/03/24 | 59.39 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | -17.14% since 05/17/24 | -12.75% since 05/17/24 | ||
| Low | 76.54 on 05/10/23 | 37.40 on 11/18/24 | 46.25 on 05/28/24 | ||
| High | 172.46 on 09/25/23 | 60.87 on 07/25/24 | 61.40 on 05/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 6,962,228 | 5,926,663 | ||
| Shares Outstanding, K | 38,150 | 182,305 | 118,014 | ||
| Annual Sales | 2,220,000 | 285,140,000 | 7,530,000 | ||
| Annual Net Income | -311,900,000 | -518,250,000 | -526,240,000 | ||
| Last Quarter Sales | 22,750,000 | 186,520,000 | 460,000 | ||
| Last Quarter Net Income | 193,000,000 | -18,200,000 | -160,550,000 | ||
| 60-Month Beta | 1.42 | 0.11 | 0.78 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | -0.34 on 11/12/24 | -1.36 on 11/06/24 | ||
| Latest Earnings Date | 11/14/23 | 11/12/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||